Kozak A, Lavrih E, Mikhaylov G, Turk B, Vasiljeva O
Pharmaceutics. 2025; 17(2).
PMID: 40006643
PMC: 11859495.
DOI: 10.3390/pharmaceutics17020276.
Izadiyan Z, Misran M, Kalantari K, Webster T, Kia P, Basrowi N
Int J Nanomedicine. 2025; 20:1213-1262.
PMID: 39911259
PMC: 11794392.
DOI: 10.2147/IJN.S488961.
Paloncyova M, Valerio M, Dos Santos R, Kuhrova P, Srejber M, cechova P
Mol Pharm. 2025; 22(3):1110-1141.
PMID: 39879096
PMC: 11881150.
DOI: 10.1021/acs.molpharmaceut.4c00744.
Ai Y, Tian Y, Qiao J, Wang C, Li H
Biomater Transl. 2024; 5(2):144-156.
PMID: 39351167
PMC: 11438609.
DOI: 10.12336/biomatertransl.2024.02.005.
Peng X, Fang J, Lou C, Yang L, Shan S, Wang Z
Acta Pharm Sin B. 2024; 14(8):3432-3456.
PMID: 39220871
PMC: 11365410.
DOI: 10.1016/j.apsb.2024.05.010.
Focused Ultrasound: Noninvasive Image-Guided Therapy.
Moonen C, Kilroy J, Klibanov A
Invest Radiol. 2024; 60(3):205-219.
PMID: 39163359
PMC: 11801465.
DOI: 10.1097/RLI.0000000000001116.
Intertumoral and intratumoral barriers as approaches for drug delivery and theranostics to solid tumors using stimuli-responsive materials.
Chenab K, Malektaj H, Nadinlooie A, Mohammadi S, Zamani-Meymian M
Mikrochim Acta. 2024; 191(9):541.
PMID: 39150483
DOI: 10.1007/s00604-024-06583-y.
Targeted Liposomal Drug Delivery: Overview of the Current Applications and Challenges.
Gatto M, Johnson M, Najahi-Missaoui W
Life (Basel). 2024; 14(6).
PMID: 38929656
PMC: 11204409.
DOI: 10.3390/life14060672.
Mild Hyperthermia Enhanced Liposomal Doxorubicin Delivery and CD8 T cell Infiltration in Triple Negative Breast Cancer.
Rezazadeh F, Saadat W, Smith R, Pattyn A, Malik M, Yazdani F
bioRxiv. 2024; .
PMID: 38712049
PMC: 11071532.
DOI: 10.1101/2024.04.25.591226.
Nanoscale strides: exploring innovative therapies for breast cancer treatment.
Mugundhan S, Mohan M
RSC Adv. 2024; 14(20):14017-14040.
PMID: 38686289
PMC: 11056947.
DOI: 10.1039/d4ra02639j.
Responsive Supramolecular Polymers for Diagnosis and Treatment.
Martinez-Orts M, Pujals S
Int J Mol Sci. 2024; 25(7).
PMID: 38612886
PMC: 11012635.
DOI: 10.3390/ijms25074077.
Artificial cells for in vivo biomedical applications through red blood cell biomimicry.
Waeterschoot J, Gossele W, Lemez S, Casadevall I Solvas X
Nat Commun. 2024; 15(1):2504.
PMID: 38509073
PMC: 10954685.
DOI: 10.1038/s41467-024-46732-8.
Metal nanoparticles for cancer therapy: Precision targeting of DNA damage.
Chen Q, Fang C, Xia F, Wang Q, Li F, Ling D
Acta Pharm Sin B. 2024; 14(3):1132-1149.
PMID: 38486992
PMC: 10934341.
DOI: 10.1016/j.apsb.2023.08.031.
USE OF ARTIFICIAL CELLS AS DRUG CARRIERS.
Diltemiz S, Tavafoghi PhD M, de Barros N, Kanada M, Heinamaki J, Contag C
Mater Chem Front. 2024; 5(18):6672-6692.
PMID: 38344270
PMC: 10857888.
DOI: 10.1039/d1qm00717c.
Box-Behnken design of thermo-responsive nano-liposomes loaded with a platinum(iv) anticancer complex: evaluation of cytotoxicity and apoptotic pathways in triple negative breast cancer cells.
Sedky N, Braoudaki M, Mahdy N, Amin K, Fawzy I, Efthimiadou E
Nanoscale Adv. 2023; 5(19):5399-5413.
PMID: 37767043
PMC: 10521260.
DOI: 10.1039/d3na00368j.
A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells.
Peng Y, Jiang H, Li B, Liu Y, Guo B, Gan W
Pharmaceutics. 2023; 15(9).
PMID: 37765221
PMC: 10537501.
DOI: 10.3390/pharmaceutics15092252.
Drug-Loaded Lipid Magnetic Nanoparticles for Combined Local Hyperthermia and Chemotherapy against Glioblastoma Multiforme.
Beola L, Iturrioz-Rodriguez N, Pucci C, Bertorelli R, Ciofani G
ACS Nano. 2023; 17(18):18441-18455.
PMID: 37698887
PMC: 10540267.
DOI: 10.1021/acsnano.3c06085.
Innovative Delivery and Release Systems for Antioxidants and Other Active Substances in the Treatment of Cancer.
Sezgin-Bayindir Z, Losada-Barreiro S, Fernandez-Bravo S, Bravo-Diaz C
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513948
PMC: 10383431.
DOI: 10.3390/ph16071038.
Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization - a Thomas Dougherty Award for Excellence in PDT paper.
De Silva P, Saad M, Thomsen H, Bano S, Ashraf S, Hasan T
J Porphyr Phthalocyanines. 2023; 24(11n12):1320-1360.
PMID: 37425217
PMC: 10327884.
DOI: 10.1142/s1088424620300098.
The Evolution and Recent Trends in Acoustic Targeting of Encapsulated Drugs to Solid Tumors: Strategies beyond Sonoporation.
Honari A, Sirsi S
Pharmaceutics. 2023; 15(6).
PMID: 37376152
PMC: 10301627.
DOI: 10.3390/pharmaceutics15061705.